Are combination therapies more effective for the treatment of relapsed refractory CLL?
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
Results of CheckMate 039 trial of nivolumab in combination with ipilimumab for Hodgkin lymphoma
Overview of a Phase I clinical trial using BGB-3111 for the treatment of relapsed CLL